When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BOLT - 3 Biotech Stocks That Sank: Are Any a Bad-News Buy?
Bolt Biotherapeutics Inc.
Last week was an especially rough one for several small biotechs. Disappointing news for Aeglea BioTherapeutics (NASDAQ: AGLE) , Bolt Biotherapeutics (NASDAQ: BOLT) , and Reata Pharmaceuticals (NASDAQ: RETA) caused shares of all three companies to plunge. In this Motley Fool Live video, recorded on Dec. 8, 2021 , Motley Fool contributors Keith Speights and Brian Orelli discuss whether any of these three biotech stocks are now bad-news buys.